Vera Therapeutics, Inc. Lessor, Operating Lease, Payment to be Received, Year One
Vera Therapeutics, Inc. (VERA) had Lessor, Operating Lease, Payment to be Received, Year One of $1.50 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity
us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths · last filed 2024-11-07
- 2024-09-30: Lessor, Operating Lease, Payment to be Received, Year One $1.50M.
- 2024-06-30: Lessor, Operating Lease, Payment to be Received, Year One $1.50M.
- 2024-03-31: Lessor, Operating Lease, Payment to be Received, Year One $1.50M.
- 2023-12-31: Lessor, Operating Lease, Payment to be Received, Year One $1.95M.
| Period end | Lessor, Operating Lease, Payment to be Received, Year One |
|---|---|
| 2024-09-30 | $1.50M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.50M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.50M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.95M 10-K · filed 2024-03-27 |
| 2023-09-30 | $1.95M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.95M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.95M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.91M 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |